Stroke Inpatient Rehabilitation Reinforcement of ACTivity

Summary

The purpose of this study is to determine the effects of daily feedback about physical activity (number of bouts of walking, duration of bouts, total walking distance, average and fastest walking speed) and walking average speed compared to feedback about walking speed only on walking-related outcomes during inpatient rehabilitation for stroke. For the first time, daily walking and other exercise will be monitored by bilateral triaxial accelerometers on the ankles. Activity-recognition algorithms will analyze the inpatient sensor data and return a summary to the participants at each site.

Conditions

• Stroke

Interventions

BEHAVIORAL

Augmented activity feedback

Feedback about walking speed and amount of physical activity will be provided 3 times per week from data acquired from wireless sensors on each ankle.

BEHAVIORAL

Speed-only feedback

Feedback about walking speed will be provided 3 times per week.

Sponsors & Collaborators

• National Taiwan University Hospital

  collaborator OTHER

• Washington University School of Medicine

  collaborator OTHER

• University of Vigo

  collaborator OTHER

• Morinomiya Hospital, Osaka, Japan

  collaborator UNKNOWN

• Mayo Clinic

  collaborator OTHER

• IRCCS San Camillo, Venezia, Italy

  collaborator OTHER

• Fairlawn Hospital, Worcester, MA, USA

  collaborator UNKNOWN

• Chonnam National University Hospital

  collaborator OTHER

• Ain Shams University

  collaborator OTHER

• MedStar National Rehabilitation Network

  collaborator OTHER

• St. Luke's Hospital, Pennsylvania

  collaborator OTHER

• Father Muller Medical College

  collaborator OTHER

• Burke Rehabilitation Hospital

  collaborator OTHER

• Burwood Hospital, Christchurch, New Zealand

  collaborator OTHER

• Gazi University

  collaborator OTHER

• University College Hospital, Ibadan, Nigeria

  collaborator UNKNOWN

• Rehabilitation Hospital, Barcelona, Spain

  collaborator UNKNOWN

• IRCCS San Raffaele

  collaborator OTHER

• University of California, Los Angeles

  lead OTHER

Principal Investigators

• Bruce H Dobkin, MD · University of California, Los Angeles

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2011-01-31

Primary Completion

2012-11-30

Completion

2012-11-30

Countries

• United States
• Egypt
• India
• Ireland
• Italy
• Japan
• New Zealand
• Nigeria
• South Korea
• Spain
• Taiwan
• Turkey (Türkiye)

Study Locations